70% enrolment of participants for Phase III clinical trial of dengue vaccine completed: Centre

India achieves a milestone in dengue prevention. The DengiAll vaccine trial sees 70% participant enrollment. ICMR leads the multi-center study across 20 Indian sites. The budget is approximately Rs 1.3 to 1.5 crore per site. Dengue cases are rising, with over 5 lakh confirmed in 2024. The government monitors outbreaks and provides support to states.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZYMrA1o
via IFTTT